The Gastritis Treatment Drugs Market is expected to register a CAGR of 4.1% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report on the Gastritis Treatment Drugs Market is segmented by drug class into proton pump inhibitors (PPIs), H2 receptor antagonists, antacids, antibiotics, and mucosal protective agents. Applications analyzed include acute gastritis, chronic gastritis, Helicobacter pylori infection, and non-infectious gastritis. End-users include hospitals, specialty clinics, retail pharmacies, and online pharmacies. The regional analysis covers key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses.
Purpose of the ReportThe report Gastritis Treatment Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Gastritis Treatment Drugs Market Segmentation
Type- Acid-Blocking Medicines
- Antibiotics
- Antacids
- Histamine Blockers
- Hospitals
- Clinics
Strategic Insights
Gastritis Treatment Drugs Market Growth Drivers- Increasing Incidence of Gastritis and Concomitant Gastric Gastrointestinal Illnesses:
One of the principal factors driving the market for the drugs used to treat gastritis is the continually increasing incidence and prevalence of gastrointestinal diseases, most particularly gastritis. Gastritis is simply inflammation of the stomach lining that afflicts millions of people throughout the world with conditions such as Helicobacter pylori (H. pylori) infection, chronic overuse of nonsteroidal anti-inflammatory drugs (NSAIDs), excessive alcohol consumption, stress, and autoimmune disorders. According to the World Gastroenterology Organization, H. Pylori infection is the cause of more than 50% of gastritis cases and has become one of the major diseases in the world. Conditions such as gastroesophageal reflux disease and peptic ulcers, closely related to gastritis, are also on the rise, and therefore, effective treatment drugs like proton pump inhibitors, H2-receptor antagonists, and antacids are in increasing demand. - Increasing Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Aspirin:
Widespread use of NSAIDs in the management of pain associated with arthritis, musculoskeletal disorders, and cardiovascular diseases has led to increased incidence of NSAID-induced gastritis. The research indicates that the long-term use of NSAIDs is the main cause of damage to the gastric mucosa, which causes inflammation, ulcers, and even gastrointestinal bleeding. The Centers for Disease Control and Prevention report that millions of people worldwide take NSAIDs daily, which increases their risk of developing gastritis-related complications. Pharmaceutical companies are now developing gastroprotective agents, such as misoprostol and PPIs, to reduce gastric irritation caused by NSAIDs. The demand for gastritis treatment drugs is expected to rise as more people rely on NSAIDs for chronic pain management, making gastritis prevention and treatment an essential part of healthcare strategies.
- Growing Awareness and Early Diagnosis of Gastric Disorders:
Improvements in diagnostic technologies like endoscopy, stool antigen tests, and breath tests for H. pylori have also improved early detection rates of gastritis. There is greater awareness of this disease through health-related campaigns initiated by healthcare institutions and government bodies to seek medical care when these patients experience the common symptoms like abdominal pain, bloating, nausea, and indigestion. The NIDDK further stresses that early intervention prevents complications such as stomach ulcers and gastric cancer. Increased access to healthcare services in emerging markets has led to a higher diagnosis rate of gastritis, which further drives the demand for effective treatment options. With the increasing focus on gastrointestinal health, the gastritis treatment drugs market is witnessing sustained growth.
- Proton Pump Inhibitors (PPIs) as First-Line Therapy:
Proton pump inhibitors (PPIs), such as omeprazole, esomeprazole, and pantoprazole, have been accepted as the most prescribed medications to treat gastritis mainly because they help reduce stomach acid, producing effective mucosal healing. Over-the-counter and prescription PPIs are currently widely available in most pharmacies, which makes them more popular in the market. On the other hand, long-term use of PPIs has been associated with various potential side effects including increased fracture risk, kidney disease, and imbalance in the gut microbiome. Due to these side effects, healthcare providers are becoming cautious about prescribing PPIs and therefore research for alternative treatment options like P-CABs and natural remedies is going on. Despite the reservations for long-term usage, PPIs remain the mainstay in the management of gastritis with pharmaceutical companies always developing new formulations for enhanced efficacy and safety. - Natural and Herbal-Based Gastritis Treatment:
The demand for natural and herbal-based remedies for gastritis treatment is increasing because patients want treatments that cause less side effect. Ingredients like licorice root, chamomile, and aloe vera have demonstrated properties of relieving gastric inflammation for the betterment of digestive health. Herbal-based antacids and supplements are found to be more in use, mainly in regions where traditional medicine occupies a significant place in the health sector. The scientific studies that have been brought out to identify the benefits of probiotics over the guts and H. pylori infection have also fueled natural remedies. Pharmaceutical and nutraceutical companies are capitalizing on this trend by formulating herbal-based treatment formulations for gastritis, thus opening a new market segment that attracts health-conscious consumers. - Advances in H. pylori Eradication Therapies:
The treatment of H. pylori-induced gastritis is changing with the development of more effective eradication regimens. The traditional triple therapy, which consists of a PPI and two antibiotics (clarithromycin and amoxicillin or metronidazole), has been the standard treatment. However, rising antibiotic resistance has led to declining success rates, necessitating new treatment approaches. Quadruple therapy, which incorporates bismuth-based regimens, and novel combination therapies, such as vonoprazan-based regimens (P-CABs), are emerging as more effective alternatives. Research is also underway for non-antibiotic therapies, including vaccines and bacteriophage treatments targeting H. pylori. The push for innovative eradication therapies is likely to drive growth in the gastritis treatment drugs market, as antibiotic resistance still remains a major challenge.
- Development of Next-Generation Acid-Reducing Drugs:
While PPIs are dominating the market, their long-term safety issues have opened the doors to novel acid-reducing therapies, like P-CABs. This new class of drugs offers acid suppression that is faster and more prolonged with less side effects. They are considered promising alternatives in this field. Next-generation pharmaceutical companies developing next-generation acid reducers with improved efficacy and safety profiles could disrupt the gastritis treatment market and help fill unmet medical needs. - Patient-specific approaches of treatment for gastric inflammation:
Advances in precision medicine are making it possible to create personalized treatments for gastritis patients based on genetic, microbiome, and metabolic factors. Research into how an individual's gut microbiome influences gastric health is paving the way for targeted probiotic therapies and microbiome-based interventions. Personalized medicine approaches can improve treatment success rates and minimize side effects, offering a chance for pharmaceutical companies to develop customized gastritis treatment solutions. - More emphasis on telemedicine and online pharmacies:
Telemedicine and digital health have facilitated easier access towards diagnosing and treating gastritis. Patients can now consult gastroenterologists online from any corner of the world and buy their prescribed drugs online. E-prescription and doorstep drug delivery facilitate higher sales of drugs for the treatment of gastritis through e-commerce. Companies that use telehealth solutions and increase their online reach enjoy higher competitive advantage against their opponents in a rapidly changing landscape of digital health care.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Gastritis Treatment Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Gastritis Treatment Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Gastritis Treatment Drugs Market is expected to register a CAGR of 4.1% from 2025-2031.
The major driving factors supporting the Gastritis Treatment Drugs Market growth are- Increasing Incidence of Gastritis and Concomitant Gastric Gastrointestinal Illnesses and Growing Awareness and Early Diagnosis of Gastric Disorders
Key Future Trends in the Gastritis Treatment Drugs Market are- Proton Pump Inhibitors (PPIs) as First-Line Therapy and Natural and Herbal-Based Gastritis Treatment
Key companies in the Gastritis Treatment Drugs Market are - Pfizer, AstraZeneca, Novartis, Cipla, Abbott Laboratories, Microbiotix, Reddy's Laboratories, Lupin Ltd, Perrigo Pharmaceutical
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Gastritis Treatment Drugs Market - By Type
1.3.2 Gastritis Treatment Drugs Market - By Application
1.3.3 Gastritis Treatment Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GASTRITIS TREATMENT DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GASTRITIS TREATMENT DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GASTRITIS TREATMENT DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. GASTRITIS TREATMENT DRUGS - GLOBAL MARKET OVERVIEW
6.2. GASTRITIS TREATMENT DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GASTRITIS TREATMENT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACID-BLOCKING MEDICINES
7.3.1. Overview
7.3.2. Acid-Blocking Medicines Market Forecast and Analysis
7.4. ANTIBIOTICS
7.4.1. Overview
7.4.2. Antibiotics Market Forecast and Analysis
7.5. ANTACIDS
7.5.1. Overview
7.5.2. Antacids Market Forecast and Analysis
7.6. HISTAMINE BLOCKERS
7.6.1. Overview
7.6.2. Histamine Blockers Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. GASTRITIS TREATMENT DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. GASTRITIS TREATMENT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Gastritis Treatment Drugs Market Overview
9.1.2 North America Gastritis Treatment Drugs Market Forecasts and Analysis
9.1.3 North America Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.1.4 North America Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Gastritis Treatment Drugs Market
9.1.5.1.1 United States Gastritis Treatment Drugs Market by Type
9.1.5.1.2 United States Gastritis Treatment Drugs Market by Application
9.1.5.2 Canada Gastritis Treatment Drugs Market
9.1.5.2.1 Canada Gastritis Treatment Drugs Market by Type
9.1.5.2.2 Canada Gastritis Treatment Drugs Market by Application
9.1.5.3 Mexico Gastritis Treatment Drugs Market
9.1.5.3.1 Mexico Gastritis Treatment Drugs Market by Type
9.1.5.3.2 Mexico Gastritis Treatment Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Gastritis Treatment Drugs Market Overview
9.2.2 Europe Gastritis Treatment Drugs Market Forecasts and Analysis
9.2.3 Europe Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.2.4 Europe Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Gastritis Treatment Drugs Market
9.2.5.1.1 Germany Gastritis Treatment Drugs Market by Type
9.2.5.1.2 Germany Gastritis Treatment Drugs Market by Application
9.2.5.2 France Gastritis Treatment Drugs Market
9.2.5.2.1 France Gastritis Treatment Drugs Market by Type
9.2.5.2.2 France Gastritis Treatment Drugs Market by Application
9.2.5.3 Italy Gastritis Treatment Drugs Market
9.2.5.3.1 Italy Gastritis Treatment Drugs Market by Type
9.2.5.3.2 Italy Gastritis Treatment Drugs Market by Application
9.2.5.4 Spain Gastritis Treatment Drugs Market
9.2.5.4.1 Spain Gastritis Treatment Drugs Market by Type
9.2.5.4.2 Spain Gastritis Treatment Drugs Market by Application
9.2.5.5 United Kingdom Gastritis Treatment Drugs Market
9.2.5.5.1 United Kingdom Gastritis Treatment Drugs Market by Type
9.2.5.5.2 United Kingdom Gastritis Treatment Drugs Market by Application
9.2.5.6 Rest of Europe Gastritis Treatment Drugs Market
9.2.5.6.1 Rest of Europe Gastritis Treatment Drugs Market by Type
9.2.5.6.2 Rest of Europe Gastritis Treatment Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Gastritis Treatment Drugs Market Overview
9.3.2 Asia-Pacific Gastritis Treatment Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Gastritis Treatment Drugs Market
9.3.5.1.1 Australia Gastritis Treatment Drugs Market by Type
9.3.5.1.2 Australia Gastritis Treatment Drugs Market by Application
9.3.5.2 China Gastritis Treatment Drugs Market
9.3.5.2.1 China Gastritis Treatment Drugs Market by Type
9.3.5.2.2 China Gastritis Treatment Drugs Market by Application
9.3.5.3 India Gastritis Treatment Drugs Market
9.3.5.3.1 India Gastritis Treatment Drugs Market by Type
9.3.5.3.2 India Gastritis Treatment Drugs Market by Application
9.3.5.4 Japan Gastritis Treatment Drugs Market
9.3.5.4.1 Japan Gastritis Treatment Drugs Market by Type
9.3.5.4.2 Japan Gastritis Treatment Drugs Market by Application
9.3.5.5 South Korea Gastritis Treatment Drugs Market
9.3.5.5.1 South Korea Gastritis Treatment Drugs Market by Type
9.3.5.5.2 South Korea Gastritis Treatment Drugs Market by Application
9.3.5.6 Rest of Asia-Pacific Gastritis Treatment Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Gastritis Treatment Drugs Market by Type
9.3.5.6.2 Rest of Asia-Pacific Gastritis Treatment Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Gastritis Treatment Drugs Market Overview
9.4.2 Middle East and Africa Gastritis Treatment Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Gastritis Treatment Drugs Market
9.4.5.1.1 South Africa Gastritis Treatment Drugs Market by Type
9.4.5.1.2 South Africa Gastritis Treatment Drugs Market by Application
9.4.5.2 Saudi Arabia Gastritis Treatment Drugs Market
9.4.5.2.1 Saudi Arabia Gastritis Treatment Drugs Market by Type
9.4.5.2.2 Saudi Arabia Gastritis Treatment Drugs Market by Application
9.4.5.3 U.A.E Gastritis Treatment Drugs Market
9.4.5.3.1 U.A.E Gastritis Treatment Drugs Market by Type
9.4.5.3.2 U.A.E Gastritis Treatment Drugs Market by Application
9.4.5.4 Rest of Middle East and Africa Gastritis Treatment Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Gastritis Treatment Drugs Market by Type
9.4.5.4.2 Rest of Middle East and Africa Gastritis Treatment Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Gastritis Treatment Drugs Market Overview
9.5.2 South and Central America Gastritis Treatment Drugs Market Forecasts and Analysis
9.5.3 South and Central America Gastritis Treatment Drugs Market Forecasts and Analysis - By Type
9.5.4 South and Central America Gastritis Treatment Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Gastritis Treatment Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Gastritis Treatment Drugs Market
9.5.5.1.1 Brazil Gastritis Treatment Drugs Market by Type
9.5.5.1.2 Brazil Gastritis Treatment Drugs Market by Application
9.5.5.2 Argentina Gastritis Treatment Drugs Market
9.5.5.2.1 Argentina Gastritis Treatment Drugs Market by Type
9.5.5.2.2 Argentina Gastritis Treatment Drugs Market by Application
9.5.5.3 Rest of South and Central America Gastritis Treatment Drugs Market
9.5.5.3.1 Rest of South and Central America Gastritis Treatment Drugs Market by Type
9.5.5.3.2 Rest of South and Central America Gastritis Treatment Drugs Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GASTRITIS TREATMENT DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GASTRITIS TREATMENT DRUGS MARKET, KEY COMPANY PROFILES
12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CIPLA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ABBOTT LABORATORIES
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MICROBIOTIX
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. REDDY'S LABORATORIES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LUPIN LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PERRIGO PHARMACEUTICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SUN PHARMACEUTICAL INDUSTRIES
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Pfizer
2. AstraZeneca
3. Novartis
4. Cipla
5. Abbott Laboratories
6. Microbiotix
7. Reddy's Laboratories
8. Lupin Ltd
9. Perrigo Pharmaceutical
10. Sun Pharmaceutical Industries
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For